LOS ANGELES CAPITAL MANAGEMENT LLC

Position in PAHC — Phibro Animal Health Corp

CIK 1177206 LOS ANGELES, CA

Back to PAHC Full portfolio

Position in PAHC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,106,406

-$2,985,819 QoQ

Shares Held

67,083

-27.1% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#43

of 206 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 21% Shared 0% None 79%

Common Shares in PAHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $64,712,202 across 30 Drug Manufacturers - Specialty & Generic names. PAHC ranks #6 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	203,548	$34,305,979
2	VTRS	Viatris Inc	751,406	$11,932,327
3	LQDA	Liquidia Corp	54,603	$4,353,497
4	KNSA	Kiniksa Pharmaceuticals International, plc	50,786	$3,247,764
5	COLL	Collegium Pharmaceutical, Inc	89,443	$3,237,836
6	PAHC	Phibro Animal Health Corp This page	67,083	$2,106,406
7	IRWD	Ironwood Pharmaceuticals Inc	342,293	$1,441,053
8	AKBA	Akebia Therapeutics, Inc.	531,813	$606,266

All Filings in PAHC

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,106,406	67,083	-27.1%	Shares	Sole	2026-08-13
2026-03-31	$5,092,225	92,067	+139.5%	Shares	Sole	2026-05-08
2025-12-31	$1,436,267	38,444	-38.2%	Shares	Sole	2026-02-11
2025-09-30	$2,514,953	62,159	-19.7%	Shares	Sole	2025-10-20
2025-06-30	$1,976,719	77,397	+250.3%	Shares	Sole	2025-08-07
2025-03-31	$471,885	22,092	-8.1%	Shares	Sole	2025-05-05
2024-12-31	$504,882	24,042	+2.1%	Shares	Sole	2025-02-04
2024-09-30	$530,098	23,539	-9.9%	Shares	Sole	2024-11-04
2024-06-30	$438,351	26,139	-10.3%	Shares	Sole	2024-08-05
2024-03-31	$376,767	29,139	—	Shares	Sole	2024-04-05
No filing history on record for this holder in this stock.